Prеglеdаnjе prеmа Аutоr Abenavoli L.


Ili, izаbеritе pismо ispоd kаkо bistе prеglеdаli prеzimе
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Prikаzivаnjе rеzultаtа 10 do 29 od 33 < prеthоdnа   slеdеćа >
Dаtum izdаvаnjаNаslоvАutоr(i)
1-јан-2012Haemophagocytic syndrome associated with mucormycosis infectionArena V.; De-Giorgio F.; Pennacchia I.; Manna R.; Vetrugno G.; Stigliano E.; Milić, Nataša ; Gasbarrini G.; Abenavoli L.
1-дец-2018Hepatitis C virus-induced hepatocellular carcinoma: A narrative reviewRužić, Maja ; Pellicano R.; Fabri M.; Luzza F.; Boccuto L.; Brkić, Miodrag; Abenavoli L.
1-мар-2017The influence of phthalates and bisphenol A on the obesity development and glucose metabolism disordersMedić Stojanoska, Milica ; Milošević, Nataša; Milić, Neda; Abenavoli L.
1-јан-2014Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3Abenavoli L.; Masarone M.; Peta V.; Milić, Nataša ; Kobyliak N.; Rouabhia S.; Persico M.
1-окт-2018Iron deficiency anemia and hearing lossLemajić Komazec, Slobodanka ; Abenavoli L.
1-јан-2015Lifestyle changes associated with a new antioxidant formulation in non-alcoholic fatty liver disease: A case seriesAbenavoli L.; Peta V.; Milić, Nataša 
1-мар-2013Liver steatosis in celiac disease: The open doorAbenavoli L.; Luigiano C.; Larussa T.; Milić, Nataša ; De Lorenzo A.; Stelitano L.; Morace C.; Consolo P.; Miraglia S.; Fagoonee S.; Virgilio C.; Luzza F.; Pellicano R.
1-јан-2014Low 25-hydroxyvitamin D3 serum levels and non-alcoholic fatty liver diseaseAbenavoli L.; Milić, Nataša ; Luigiano C.
21-авг-2016Metabolic aspects of adult patients with nonalcoholic fatty liver diseaseAbenavoli L.; Milić, Neda; Di Renzo L.; Preveden, Andrej; Medić Stojanoska, Milica ; De Lorenzo A.
1-јан-2014Metformin in the treatment of non-alcoholic fatty liver disease: Safety, efficacy and mechanismRouabhia S.; Milić, Nataša ; Abenavoli L.
1-нов-2018Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseasesAbenavoli L.; Izzo A.; Milić, Nataša ; Cicala C.; Santini A.; Capasso R.
1-мар-2011Milk thistle for treatment of nonalcoholic fatty liver diseaseAbenavoli L.; Aviello G.; Capasso R.; Milić, Nataša ; Capasso F.
1-окт-2010Milk thistle in liver diseases: Past, present, futureAbenavoli L.; Capasso R.; Milić, Nataša ; Capasso F.
1-јан-2015Non-alcoholic fatty liver disease severity, central fat mass and adinopectin: A close relationshipAbenavoli L.; Di Renzo L.; Guzzi P.; Pellicano R.; Milić, Nataša ; De Lorenzo A.
1-јан-2019Olive oil antioxidants and non-alcoholic fatty liver diseaseAbenavoli L.; Milanović, Maja ; Milić, Nataša ; Luzza F.; Giuffrè A.
1-феб-2013A pathogenetic link between non-alcoholic fatty liver disease and celiac diseaseAbenavoli L.; Milić, Nataša ; De Lorenzo A.; Luzza F.
1-јан-2014Pharmacotherapy of acute alcoholic hepatitis in clinical practiceAbenavoli L.; Milić, Nataša ; Rouabhia S.; Addolorato G.
1-јан-2014Phytotherapy and nafld-rom goals and challenges to clinical practiceMilošević, Nataša; Milanović, Maja; Abenavoli L.; Milić, Nataša 
1-мар-2019Polycystic ovary syndrome and Vitamin D serum levelsĆetković, Nenad ; Pellicano R.; Bjelica, Artur ; Abenavoli L.
1-јун-2016Prevention program for Clostridium difficile infection: A single-centre Serbian experienceBrkić, Snežana ; Pellicano R.; Turkulov, Vesna ; Radovanović, M.; Abenavoli L.